PubMed Health⌕ Search

Biomedical subjects

F Vahrenwald

Publications and source records attributed to F Vahrenwald.

2 recordsLinked to original sources

Toxic reactions of oxidized LDL on cells of acute myeloid leukemia.

In AML patients LDL concentration of the serum is reduced due to the high LDL receptor activity of the AML cells. This phenomenon enables the use of LDL particles as vehicles for drug targeting. Toxic lipid peroxides and aldehydes were introduced into LDL particles by the simple but effective oxidation with 10 microM CuSO4. Up to 250 nmol peroxides and 6 nmol malondialdehyde were formed per mg LDL protein within 30 h of oxidation. This oxidized LDL is effectively taken up by AML cells of the FAB type M3 and M5 indicating the presence of scavenger receptors on these cells. Within 96 h 61-84% of the AML cells are killed by the oxidized LDL. Our results open a possibility to achieve specificity for targeting lipophilic antineoplastic drugs towards AML cells using oxidized LDL as vehicles. The use of oxidized LDL as drug carrier is recommended for purging of AML bone marrow because hematopoietic stem cells that don't possess scavenger receptors are protected from toxic action.

Copper Sulfate↗

Cholesterol based antineoplastic strategies.

Manipulation of cholesterol metabolism open several possibilities of interfering with the growth of malignant cells. Deprivation of cholesterol decreases the velocity of growth and alters the composition of the cell membrane. The high requirement for LDL of malignant cells can be utilized for drug targeting. Proliferation assays were performed with neuroblastoma cells and cell lines of acute myeloid leukemia deprived of cholesterol by inhibition of HMG-CoA-reductase or culture in LDL-deficient medium. The cholesterol content of the cell membrane when reduced to 50% had no effect on the toxicity of LAK-cells but the toxicity of the fluorescent dye merocyanine MC 540 was enhanced two-fold. LDL-mediated drug targeting to AML cells was performed with oxidized LDL and showed toxic reactions. These results proved that cholesterol deprivation could be used to support some therapeutic approaches.

Anticholesteremic Agents↗